Alnylam Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
2,500
Employees2,500
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
2,500
Employees2,500

ALNY Key Statistics

Market cap
29.37B
Market cap29.37B
Price-Earnings ratio
37.20
Price-Earnings ratio37.20
Dividend yield
Dividend yield
Average volume
3.17M
Average volume3.17M
High today
$223.44
High today$223.44
Low today
$216.50
Low today$216.50
Open price
$217.41
Open price$217.41
Volume
683.23K
Volume683.23K
52 Week high
$495.55
52 Week high$495.55
52 Week low
$197.81
52 Week low$197.81

Stock Snapshot

Alnylam Pharmaceuticals(ALNY) stock is priced at $219.51, giving the company a market capitalization of 29.37B. It carries a P/E multiple of 37.20.

On 2026-08-11, Alnylam Pharmaceuticals(ALNY) stock moved within a range of $216.50 to $223.44. With shares now at $219.51, the stock is trading +1.4% above its intraday low and -1.8% below the session's peak.

Trading volume for Alnylam Pharmaceuticals(ALNY) stock has reached 683.23K, versus its average volume of 3.17M.

The stock's 52-week range extends from a low of $197.81 to a high of $495.55.

The stock's 52-week range extends from a low of $197.81 to a high of $495.55.

ALNY News

TipRanks 9h
Raymond James Is Betting Big on These 2 ‘Strong Buy’ Stocks

The S&P 500 is now sitting just below its record high, with another strong earnings season helping stocks remain near their highs. The strength has not been lim...

Benzinga 1d
$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today - Benzinga

...

$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today - Benzinga

Analyst ratings

77%

of 30 ratings
Buy
76.7%
Hold
23.3%
Sell
0%

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.